Fiera Capital (Canada)’s Ligand Pharmaceuticals LGND Stock Holding History

Fiera Capital (Canada)’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.4M	Sell	77,348 -57,964	-43%	-$13.7M	0.09%	157
2026 Q1	$27M	Buy	135,312 +4,076	+3%	+$806K	0.09%	164
2025 Q4	$24.8M	Buy	+131,236	New	+$25.2M	0.08%	170
2019 Q3	–	Sell	-16,926	Closed	-$1.21M	–	670
2019 Q2	$1.21M	Sell	16,926 -838	-5%	-$61.7K	﹤0.01%	436
2019 Q1	$1.39M	Sell	17,764 -7,575	-30%	-$574K	0.01%	439
2018 Q4	$2.15M	Buy	+25,339	New	+$2.7M	0.01%	383

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fiera Capital (Canada)'s LGND Position: Q2 2026 in Review

Fiera Capital (Canada) reduced its Ligand Pharmaceuticals (LGND) stake by 43% in Q2 2026, selling an estimated $13.7M and leaving 77,348 shares worth $24.4M. The position accounts for 0.09% of the portfolio, ranked #157.

Fiera Capital (Canada) first reported a position in LGND in Q4 2018 and has held it in 6 quarters since. The position peaked at $27M in Q1 2026. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Fiera Capital (Canada) held 77,348 shares of Ligand Pharmaceuticals worth $24.4M as of Q2 2026.
Fiera Capital (Canada) sold 57,964 Ligand Pharmaceuticals shares in Q2 2026, an estimated $13.7M.
Ligand Pharmaceuticals made up 0.09% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #157 holding.
Fiera Capital (Canada) first reported a position in Ligand Pharmaceuticals in Q4 2018 and has held it in 6 quarters since.
Fiera Capital (Canada)'s Ligand Pharmaceuticals position peaked at $27M in Q1 2026.
416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.